{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:02:15Z","timestamp":1791338535012,"version":"4.3.1"},"reference-count":83,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["Salud-2003-099"],"award-info":[{"award-number":["Salud-2003-099"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016928","name":"Instituto Nacional de Pediatr\u00eda","doi-asserted-by":"publisher","award":["03-2006"],"award-info":[{"award-number":["03-2006"]}],"id":[{"id":"10.13039\/100016928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Anticancer regimens for Hodgkin lymphoma (HL) patients include highly genotoxic drugs that have been very successful in killing tumor cells and providing a 90% disease-free survival at five years. However, some of these treatments do not have a specific cell target, damaging both cancerous and normal cells. Thus, HL survivors have a high risk of developing new primary cancers, both hematologic and solid tumors, which have been related to treatment. Several studies have shown that after treatment, HL patients and survivors present persistent chromosomal instability, including nonclonal chromosomal aberrations. The frequency and type of chromosomal abnormalities appear to depend on the type of therapy and the cell type examined. For example, MOPP chemotherapy affects hematopoietic and germ stem cells leading to long-term genotoxic effects and azoospermia, while ABVD chemotherapy affects transiently sperm cells, with most of the patients showing recovery of spermatogenesis. Both regimens have long-term effects in somatic cells, presenting nonclonal chromosomal aberrations and genomic chaos in a fraction of noncancerous cells. This is a source of karyotypic heterogeneity that could eventually generate a more stable population acquiring clonal chromosomal aberrations and leading towards the development of a new cancer.<\/jats:p>","DOI":"10.3390\/genes10010037","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T04:10:16Z","timestamp":1547179816000},"page":"37","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Nonclonal Chromosome Aberrations and Genome Chaos in Somatic and Germ Cells from Patients and Survivors of Hodgkin Lymphoma"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-6368","authenticated-orcid":false,"given":"Sara","family":"Frias","sequence":"first","affiliation":[{"name":"Laboratorio de Citogen\u00e9tica, Instituto Nacional de Pediatr\u00eda, Cd. De Mexico, P.O. Box 04530, Mexico"},{"name":"Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de Mexico, Cd. De Mexico, P.O. Box 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ramos","sequence":"additional","affiliation":[{"name":"Laboratorio de Citogen\u00e9tica, Instituto Nacional de Pediatr\u00eda, Cd. De Mexico, P.O. Box 04530, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Salas","sequence":"additional","affiliation":[{"name":"Laboratorio de Gen\u00e9tica y C\u00e1ncer, Instituto Nacional de Pediatr\u00eda, Cd. De Mexico, P.O. Box 04530, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertha","family":"Molina","sequence":"additional","affiliation":[{"name":"Laboratorio de Citogen\u00e9tica, Instituto Nacional de Pediatr\u00eda, Cd. De Mexico, P.O. Box 04530, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Laboratorio de Citogen\u00e9tica, Instituto Nacional de Pediatr\u00eda, Cd. De Mexico, P.O. Box 04530, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rivera-Luna","sequence":"additional","affiliation":[{"name":"Subdirecci\u00f3n de Hemato-Oncolog\u00eda, Instituto Nacional de Pediatr\u00eda, Cd. De Mexico, P.O. Box 04530, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Engert, A., and Horning, S.J. (2015). Hodgkin Lymphoma: A Comprehensive Update on Diagnostics and Clinics, Springer. [2nd ed.]. Hodgkin Lymphoma: A Comprehensive Overview.","DOI":"10.1007\/978-3-319-12505-3"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2015.07.005","article-title":"Hodgkin Lymphoma: Diagnosis and Treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"De Fine Licht, S., Rugbjerg, K., Gudmundsdottir, T., Bonnesen, T.G., Asdahl, P.H., Holmqvist, A.S., Madanat-Harjuoja, L., Tryggvadottir, L., Wesenberg, F., and Hasle, H. (2017). Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002296"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/MPH.0000000000000462","article-title":"Incidence of Childhood Hodgkin Lymphoma in Mexico by Histologic Subtypes and Socioeconomic Regions","volume":"38","year":"2016","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_6","unstructured":"Kaseb, H., and Babiker, H. (2018). Cancer, Lymphoma, Hodgkin, StatPearls Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Weniger, M., Barth, T., and M\u00f6ller, P. (2006). Genomic Alterations in Hodgkin\u2019s Lymphoma. Int. J. Hematol.","DOI":"10.1532\/IJH97.06048"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cuceu, C., Hempel, M.W., Sabatier, L., Bosq, J., Carde, P., and M\u2019kacher, R. (2018). Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives. Cancers, 10.","DOI":"10.3390\/cancers10040091"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3324\/haematol.2015.135475","article-title":"Whole exome sequencing in families at high risk for Hodgkin lymphoma: Identification of a predisposing mutation in the KDR gene","volume":"101","author":"Rotunno","year":"2016","journal-title":"Haematologica"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Knecht, H., and Mai, S. (2017). LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin\u2019s Lymphoma. Viruses, 9.","DOI":"10.3390\/v9070164"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijrobp.2007.01.050","article-title":"Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin\u2019s lymphoma prior to any treatment are predictive of second cancers","volume":"68","author":"Girinsky","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-1110(80)90012-3","article-title":"The genetic toxicology of nitrogen and sulphur mustard","volume":"75","author":"Fox","year":"1980","journal-title":"Mutat. Res. Genet. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0165-1110(94)90015-9","article-title":"DNA damage and mutagenesis induced by nitrogen mustards","volume":"318","author":"Povirk","year":"1994","journal-title":"Mutat. Res. Genet. Toxicol."},{"key":"ref_14","first-page":"36","article-title":"Treatment of early stages of Hodgkin\u2019s disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy","volume":"31","author":"Hagemeister","year":"1995","journal-title":"Semin Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0277-5379(85)90088-4","article-title":"Gonadal toxicity after combination chemotherapy for hodgkins disease comparative results of MOPP vs ABVD","volume":"21","author":"Viviani","year":"1985","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/pbc.25935","article-title":"ABVD-Based Therapy for Hodgkin Lymphoma in Children and Adolescents: Lessons Learnt in a Tertiary Care Oncology Center in a Developing Country","volume":"63","author":"Jain","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2015-07-641035","article-title":"Hodgkin lymphoma in children and adolescents: Improving the therapeutic index","volume":"126","author":"Kelly","year":"2015","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/annonc\/mdh273","article-title":"Solid tumors in patients treated for Hodgkin\u2019s disease: A report from the German Hodgkin Lymphoma Study Group","volume":"15","author":"Behringer","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"Engert","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Journy, N., Mansouri, I., Allodji, R.S., Demoor-Goldschmidt, C., Ghazi, D., Haddy, N., Rubino, C., Veres, C., Zrafi, W.S., and Rivera, S. (2018). Volume effects of radiotherapy on the risk of second primary cancers: A systematic review of clinical and epidemiological studies. Radiother. Oncol.","DOI":"10.1016\/j.radonc.2018.09.017"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/78.4.553","article-title":"The radical radiotherapy of regionally localized Hodgkin\u2019s disease","volume":"78","author":"Kaplan","year":"1962","journal-title":"Radiology"},{"key":"ref_22","first-page":"258797","article-title":"Role of Radiotherapy in Modern Treatment of Hodgkin\u2019s Lymphoma","volume":"2011","author":"Yeoh","year":"2010","journal-title":"Adv. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11899-009-0017-2","article-title":"Does radiotherapy still have a place in Hodgkin lymphoma?","volume":"4","author":"Yahalom","year":"2009","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0360-3016(76)90172-3","article-title":"Radiation doses following intensive chemotherapy in the treatment of hodgkin\u2019s disease","volume":"1","author":"Prosnitz","year":"1976","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.rpor.2012.05.003","article-title":"Role of modern radiation therapy in early stage Hodgkin\u2019s lymphoma: A young radiation oncologists\u2019 perspective","volume":"17","author":"Filippi","year":"2012","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1383-5718(01)00237-6","article-title":"Genotoxic effects of radiotherapy and chemotherapy on circulating lymphocytes in patients with Hodgkin\u2019s disease","volume":"497","author":"Bilban","year":"2001","journal-title":"Mutat. Res. Toxicol. Environ. Mutagen."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0360-3016(92)90722-T","article-title":"The frequency of translocations after treatment for Hodgkin\u2019s disease","volume":"24","author":"Smith","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","first-page":"12","article-title":"Bystander effects and radiotherapy","volume":"20","author":"Alvarenga","year":"2014","journal-title":"Reports Pract. Oncol. Radiother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mrgentox.2015.08.008","article-title":"Chromosomal instability\u2014Mechanisms and consequences","volume":"793","author":"Venkatesan","year":"2015","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"ref_30","first-page":"213","article-title":"Photons\u2013Radiobiological issues related to the risk of second malignancies","volume":"42","author":"Marcu","year":"2017","journal-title":"Phys. Med. Eur. J. Med. Phys."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0027-5107(96)00029-2","article-title":"Mutagenicity of anticancer drugs in mammalian germ cells","volume":"355","author":"Witt","year":"1996","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0889-8588(05)70378-6","article-title":"Toxicity of chemotherapy","volume":"10","author":"Lowenthal","year":"1996","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/em.21691","article-title":"Persistent genomic instability in peripheral blood lymphocytes from hodgkin lymphoma survivors","volume":"53","author":"Salas","year":"2012","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/bjc.2017.177","article-title":"Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors","volume":"117","author":"Schaapveld","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/asheducation-2016.1.323","article-title":"Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment","volume":"2016","author":"Ng","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."},{"key":"ref_36","first-page":"53","article-title":"Genetic abnormalities in leukemia secondary to treatment in patients with Hodgkin\u2019s disease","volume":"63","author":"Salas","year":"2011","journal-title":"Rev. Investig. Clin. Transl. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10555-013-9427-7","article-title":"Chromosomal instability (CIN): What it is and why it is crucial to cancer evolution","volume":"32","author":"Heng","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/ajmg.a.32315","article-title":"Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: Delineation of clinical subtypes","volume":"146A","author":"Rivera","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"R986","DOI":"10.1016\/j.cub.2017.07.043","article-title":"Fanconi anemia pathway","volume":"27","year":"2017","journal-title":"Curr. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-De Teresa, B., Hern\u00e1ndez-G\u00f3mez, M., and Fr\u00edas, S. (2017). DNA Damage as a Driver for Growth Delay: Chromosome Instability Syndromes with Intrauterine Growth Retardation. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/8193892"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mc.22539","article-title":"Emerging links among Chromosome Instability (CIN), cancer, and aging","volume":"56","author":"Rao","year":"2017","journal-title":"Mol. Carcinog."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Rangel, N., Forero-Castro, M., and Rondon-Lagos, M. (2017). New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy Response. Genes, 8.","DOI":"10.3390\/genes8060155"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000348682","article-title":"Karyotype Heterogeneity and Unclassified Chromosomal Abnormalities","volume":"139","author":"Heng","year":"2013","journal-title":"Cytogenet. Genome Res."},{"key":"ref_44","unstructured":"Michael, G.B., and Ried, T. (2015). Chromosomal Instability in Cancer Cells, Springer International Publishing."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13008-015-0009-7","article-title":"Aneuploidy and chromosomal instability in cancer: A jackpot to chaos","volume":"10","author":"Giam","year":"2015","journal-title":"Cell Div."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1139\/g06-023","article-title":"Clonal and non-clonal chromosome aberrations and genome variation and aberration","volume":"49","author":"Heng","year":"2006","journal-title":"Genome"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4161\/cc.27378","article-title":"Genome chaos Survival strategy during crisis","volume":"13","author":"Liu","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ramos, S., Navarrete-Meneses, P., Molina, B., Cervantes-Barrag\u00e1n, D.E., Lozano, V., Gallardo, E., Marchetti, F., and Frias, S. (2018). Genomic chaos in peripheral blood lymphocytes of Hodgkin\u2019s lymphoma patients one year after ABVD chemotherapy\/radiotherapy. Environ. Mol. Mutagen., 768.","DOI":"10.1002\/em.22216"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13039-016-0223-2","article-title":"Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?","volume":"9","author":"Heng","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13039-018-0376-2","article-title":"Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems","volume":"11","author":"Ye","year":"2018","journal-title":"Mol. Cytogenet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0360-3016(03)00578-9","article-title":"Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin\u2019s lymphoma patients","volume":"57","author":"Girinsky","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-4608(00)00236-3","article-title":"Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: Relationship with cancer-related genes and fragile sites","volume":"121","author":"Sierrasesumaga","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/0955300031000102650","article-title":"Persistence of chromosome aberrations in peripheral lymphocytes from Hodgkin\u2019s lymphoma remission patients","volume":"79","author":"Ryabchenco","year":"2003","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/annonc\/mdp375","article-title":"JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin\u2019s lymphoma patients and poor clinical outcome","volume":"21","author":"Andreoletti","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s11658-018-0121-1","article-title":"Latent viruses can cause disease by disrupting the competition for the limiting factor p300\/CBP","volume":"23","author":"Polansky","year":"2018","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Nandakumar, A., Uwatoko, F., Yamamoto, M., Tomita, K., Majima, H.J., Akiba, S., and Koriyama, C. (2017). Radiation-induced Epstein\u2013Barr virus reactivation in gastric cancer cells with latent EBV infection. Tumor Biol., 39.","DOI":"10.1177\/1010428317717718"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000323627","article-title":"Treatment of Akata EBV-Positive Cells with Doxorubicin Causes More EBV Reactivation than Treatment with Etoposide","volume":"57","author":"Lima","year":"2011","journal-title":"Chemotherapy"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/nar\/gkp1169","article-title":"Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells","volume":"38","author":"Wu","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/1557988316643383","article-title":"The Disappearing Sperms: Analysis of Reports Published Between 1980 and 2015","volume":"11","author":"Sengupta","year":"2017","journal-title":"Am. J. Mens. Health"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jncimonographs\/lgi001","article-title":"Relative Susceptibilities of Male Germ Cells to Genetic Defects Induced by Cancer Chemotherapies","volume":"2005","author":"Wyrobek","year":"2005","journal-title":"JNCI Monogr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198711193172104","article-title":"Effects of Treatment on Fertility in Long-Term Survivors of Childhood or Adolescent Cancer","volume":"317","author":"Byrne","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.1984.2.6.571","article-title":"Recovery of spermatogenesis after treatment for Hodgkin\u2019s disease: Limiting dose of MOPP chemotherapy","volume":"2","author":"Meistrich","year":"1984","journal-title":"J. Clin. Oncol."},{"key":"ref_64","first-page":"155","article-title":"Risk of infertility in patients with Hodgkin\u2019s disease treated with ABVD vs MOPP vs ABVD\/MOPP","volume":"75","author":"Anselmo","year":"1990","journal-title":"Haematologica"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1439-0272.1995.tb01078.x","article-title":"Male reproductive potential after MOPP therapy for Hodgkin\u2019s disease: A long-term survey","volume":"27","author":"Marmor","year":"1995","journal-title":"Andrologia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1200\/JCO.1997.15.12.3488","article-title":"Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin\u2019s disease","volume":"15","author":"Meistrich","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"667.e3","DOI":"10.1016\/j.fertnstert.2014.06.008","article-title":"Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: A multicenter prospective study from the CECOS network","volume":"102","author":"Bujan","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"341.e5","DOI":"10.1016\/j.fertnstert.2016.10.001","article-title":"Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: A prospective study by the French CECOS network","volume":"107","author":"Martinez","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of Advanced Hodgkin\u2019s Disease with MOPP, ABVD, or MOPP Alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_70","unstructured":"S\u00e1nchez, S., Molina, B., Niembro, A., Rivera-Luna, R., Frias, G., Carnevale, A., Ulloa-Aguirre, A., Badillo, D., Cervantes, D., and Lozano, V. Evaluaci\u00f3n de la funci\u00f3n gonadal en pacientes con enfermedad de Hodgkin tratados con ABVD o MOPP. Proceedings of the XIII Encuentro Nacional de Investigadores en Salud. Comisi\u00f3n Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Oax, M\u00e9xico."},{"key":"ref_71","first-page":"44","article-title":"NOVP Chemotherapy for Hodgkin\u2019s Disease Transiently Induces Sperm Aneuploidies Associated with the Major Clinical Aneuploidy Syndromes Involving Chromosomes X, Y, 18, and 21","volume":"63","author":"Frias","year":"2003","journal-title":"Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jnci\/95.13.928","article-title":"Radiation therapy in the treatment of Hodgkin\u2019s disease\u2014Do you see what I see?","volume":"95","author":"Longo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.fertnstert.2007.02.010","article-title":"Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma","volume":"89","author":"Blumenfeld","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/annonc\/mdr575","article-title":"Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial","volume":"23","author":"Behringer","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/annonc\/mdl149","article-title":"Treatment-related premature ovarian failure as a long-term complication after Hodgkin\u2019s lymphoma","volume":"17","author":"Haukvik","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review","volume":"36","author":"Haupt","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00212026","article-title":"Chromosomal damage in sperm of patients surviving Hodgkin\u2019s disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy","volume":"93","author":"Brandriff","year":"1994","journal-title":"Hum. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng0597-74","article-title":"Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm","volume":"16","author":"Robbins","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/humrep\/dem389","article-title":"Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin\u2019s lymphoma patients","volume":"23","author":"Tempest","year":"2008","journal-title":"Hum. Reprod."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Patassini, C., Garolla, A., Bottacin, A., Menegazzo, M., Speltra, E., Foresta, C., and Ferlin, A. (2013). Molecular Karyotyping of Human Single Sperm by Array-Comparative Genomic Hybridization. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060922"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000454964","article-title":"Of Simple and Complex Genome Rearrangements, Chromothripsis, Chromoanasynthesis, and Chromosome Chaos","volume":"8","author":"Poot","year":"2017","journal-title":"Mol. Syndromol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.29031","article-title":"Evolutionary mechanism unifies the hallmarks of cancer","volume":"136","author":"Horne","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/gutjnl-2016-312608","article-title":"Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkins lymphoma treatment","volume":"67","author":"Rigter","year":"2018","journal-title":"Gut"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/1\/37\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:25:01Z","timestamp":1760185501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/1\/37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["genes10010037"],"URL":"https:\/\/doi.org\/10.3390\/genes10010037","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201811.0269.v1","asserted-by":"object"}]},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]}}}